Type(s) of Cancer
Leukemia/Lymphoma,Sarcoma
Leukemia/Lymphoma,Sarcoma
Study Phase
Phase 3
Study Completion Date
March 2019
March 2019
NCT01371981Uploaded 03-24-2021
Access via NCI by Request
PDS UID: nci-data-461
A Phase III Randomized Trial for Patients With De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients With High Allelic Ratio FLT3/ITD
Files: NCT01371981-D4



Data DictionaryNCT01371981-D4-Data-Dictionary_1.pdf

DATANCT01371981-D4-Dataset.csv

OTHERREADME.pdf